ADAR1 Capital Management »

Indivior shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Indivior (INDV) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Indivior

Tip: Access up to 7 years of quarterly data

All positions including Indivior held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $591k 28k 21.42
2023-12-31 $368k 24k 15.27

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Indivior

Two Seas Capital
FMR
Scopia Management
Vanguard Group
Goldman Sachs Group
Bank of America Corporation
Barclays
Bank Of Montreal
Jpmorgan Chase & Co
UBS Group
Liontrust Investment Partners
Acadian Asset Management
Artemis Investment Management
Boothbay Fund Management
Credit Agricole

View all funds holding Indivior